Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Fujifilm Holdings Corp | 11 |
| 2 | The University of Texas System | 6 |
| 3 | Institut National de la Santé et de la Recherche Médicale | 4 |
| 4 | 4SC AG | 3 |
| 5 | Cornell University | 3 |
| 6 | Johns Hopkins University | 3 |
| 7 | Universitair Medisch Centrum Utrecht | 3 |
| 8 | Utah System of Higher Education | 3 |
| 9 | Roche Holding AG | 2 |
| 10 | State University System of Florida | 2 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 58 |
| 2 | A61K | Medicinal preparations | 53 |
| 3 | A61P | Therapeutic activity (drug indications) | 48 |
| 4 | G01N | Investigating / analysing materials | 35 |
| 5 | C12Q | Measuring/testing involving enzymes | 18 |
| 6 | A61L | Sterilising / disinfecting materials | 10 |
| 7 | C07K | Peptides | 9 |
| 8 | C07H | Sugars and derivatives | 6 |
| 9 | A23L | Foods and beverages (general) | 5 |
| 10 | A23V | Foods, foodstuffs - indexing scheme | 5 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Micromolecular compound combination, kit and the application reprogrammed for the cell of differentiation | 2018 | 18 | |
| ORGAN PROTECTION | 2010 | 16 | |
| The method that micromolecular compound combines and prepares vascular smooth muscle cells using the cell that micromolecular compound combination induction is broken up | 2018 | 7 | |
| CYCLIC ADENOSINE MONOPHOSPHATE COMPOUNDS FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS | 2007 | 15 | |
| METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS | 2023 | 2 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Frank Schwede | Biolog Life Science Institute | 9 |
| 2 | Oleg G. Chepurny | SUNY Upstate Medical University | 8 |
| 3 | George G. Holz | SUNY Upstate Medical University | 8 |
| 4 | Hans‐Gottfried Genieser | Biolog Life Science Institute | 6 |
| 5 | Johannes L. Bos | University Medical Center Utrecht | 6 |
| 6 | Igor Dzhura | SUNY Upstate Medical University | 6 |
| 7 | Colin A. Leech | SUNY Upstate Medical University | 6 |
| 8 | Elvira Dzhura | SUNY Upstate Medical University | 5 |
| 9 | Martina Schmidt | University of Groningen | 3 |
| 10 | Eva Degerman | Lund University | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Cyclic AMP Potentiates Vascular Endothelial Cadherin-Mediated Cell-Cell Contact To Enhance Endothelial Barrier Function through an Epac-Rap1 Signaling Pathway | 2004 | 415 | Nitric Oxide and Endothelin Effects |
| Epac-selective cAMP Analog 8-pCPT-2′-O-Me-cAMP as a Stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic β-Cells | 2003 | 298 | Diabetes Treatment and Management |
| The cAMP binding protein Epac modulates Ca 2+ sparks by a Ca 2+ /calmodulin kinase signalling pathway in rat cardiac myocytes | 2007 | 208 | Cardiac electrophysiology and arrhythmias |
| Prostaglandin E2inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling | 2006 | 175 | Pulmonary Hypertension Research and Treatments |
| Protein Kinase B Is Obligatory for Follicle-Stimulating Hormone-Induced Granulosa Cell Differentiation | 2003 | 169 | Protein Kinase Regulation and GTPase Signaling |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 8-pCPT-2'-O-Me-cAMP?
Which organizations hold the most patents involving this compound?
What research focus areas are represented in the patent portfolio?
Who are the most prolific authors publishing on this compound?
What is the recent publication and patent activity trend for this compound?